Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women

BMJ Open

Volumn 8, Issue 3, 2018, Pages

  Khaw, Kay Tee ^a   Sharp, Stephen J ^a   Finikarides, Leila ^b,c   Afzal, Islam ^d   Lentjes, Marleen ^a   Luben, Robert ^a   Forouhi, Nita G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b BBC RESEARCH AND DEVELOPMENT   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ASTON UNIVERSITY   (United Kingdom)

Author keywords

blood lipids; coconut oil; dietary fats; olive oil; randomized trial

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COCONUT OIL; EXTRA VIRGIN OLIVE OIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLIVE OIL; TRIACYLGLYCEROL; CHOLESTEROL; FATTY ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; BUTTER; CARDIOVASCULAR RISK; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FAT INTAKE; FEMALE; FOLLOW UP; FOOD COMPOSITION; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPID DIET; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NUTRITIONAL ASSESSMENT; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POPULATION; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; WAIST CIRCUMFERENCE; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; COCONUT; CONTROLLED STUDY; DIET; MIDDLE AGED; OLIVE TREE; PHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; RISK FACTOR;

AGED; BUTTER; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COCONUT OIL; COCOS; DIET; DIETARY FATS; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; OLEA; OLIVE OIL; REFERENCE VALUES; RISK FACTORS;

EID: 85044178102     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-020167     Document Type: Article

References (42)

1. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modifcation Trial. JAMA 2006;295:655-66.
2. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a mediterranean diet. N Engl J Med Overseas Ed 2013;368:1279-90.
3. Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 2014;160:398-406.
4. Hooper L, Martin N, Abdelhamid A, et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane DatabaseSyst Rev 2015;6:CD011737.
5. Alexander DD, Bylsma LC, Vargas AJ, et al. Dairy consumption and CVD: a systematic review and meta-analysis. Br J Nutr 2016;115:737-50.
6. Liang J, Zhou Q, Kwame Amakye W, et al. Biomarkers of dairy fat intake and risk of cardiovascular disease: A systematic review and meta analysis of prospective studies. Crit Rev Food Sci Nutr 2016:1-9.
7. Pimpin L, Wu JH, Haskelberg H, et al. Is Butter Back? A systematic review and meta-analysis of butter consumption and risk of cardiovascular disease, diabetes, and total mortality. PLoS One 2016;11:e0158118.
8. Department of Health and Human Services U, Department of Agriculture (US). 2015-2020 Dietary Guidelines for Americans. 8th Edition, 2015.
9. Eyres L, Eyres M F, Chisholm A, et al. Coconut oil consumption and cardiovascular risk factors in humans. Nutr Rev 2016;74:267-80.
10. Cox C, Mann J, Sutherland W, et al. Effects of coconut oil, butter, and saffower oil on lipids and lipoproteins in persons with moderately elevated cholesterol levels. J Lipid Res 1995;36:1787-95.
11. Cox C, Sutherland W, Mann J, et al. Effects of dietary coconut oil, butter and saffower oil on plasma lipids, lipoproteins and lathosterol levels. Eur J Clin Nutr 1998;52:650-4.
12. Sacks FM, Lichtenstein AH, Wu JHY, et al. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation 2017;136:e1-e23.
13. Estruch R, Martínez-González MA, Corella D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006;145:1-11.
14. Hohmann CD, Cramer H, Michalsen A, et al. Effects of high phenolic olive oil on cardiovascular risk factors: A systematic review and meta-analysis. Phytomedicine 2015;22:631-40.
15. Liu B, Young H, Crowe FL, et al. Development andevaluation of the Oxford WebQ, a low-cost, web-based method for assessment ofprevious 24 h dietary intakes in large-scale prospective studies. Public HealthNutr 2011;14:1998-2005.
16. Hagen JH, Hagen PB. An enzymic method for the estimation of glycerol in blood and its use to determine the effect of noradrenaline on the concentration of glycerol in blood. Can J Biochem Physiol 1962;40:1129-39.
17. Rautela GS, Liedtke RJ. Automated enzymic measurement of total cholesterol in serum. Clin Chem 1978;24:108-14.
18. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 2002;48:236-54.
19. Canoy D, Wareham N, Luben R, et al. Serum lipid concentration in relation to anthropometric indices of central and peripheral fat distribution in 20, 021 British men and women: results from the EPIC-Norfolk population-based cohort study. Atherosclerosis 2006;189:420-7.
20. Forouhi NG, Menon RK, Sharp SJ, et al. Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial. Diabetes Obes Metab 2016;18:392-400.
21. Borm G F, Fransen J, Lemmens WA. A simple samplesize formula for analysis of covariance in randomized clinical trials. J ClinEpidemiol 2007;60:1234-8.
22. Clarke R, Frost C, Collins R, et al. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997;314:112-7.
23. Reiser R, Probstfeld JL, Silvers A, et al. Plasma lipid and lipoprotein response of humans to beef fat, coconut oil and saffower oil. Am J Clin Nutr 1985;42:190-7.
24. Voon PT, Ng TK, Lee VK, et al. Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and infammatory markers in healthy Malaysian adults. Am J Clin Nutr 2011;94:1451-7.
25. Engel S, Tholstrup T. Butter increased total and LDL cholesterol compared with olive oil but resulted in higher HDL cholesterol compared with a habitual diet. Am J Clin Nutr 2015;102:309-15.
26. Vijayakumar M, Vasudevan DM, Sundaram KR, et al. A randomized study of coconut oil versus sunfower oil on cardiovascular risk factors in patients with stable coronary heart disease. Indian Heart J 2016;68:498-506.
27. Hernáez Á, Fernández-Castillejo S, Farràs M, et al. Olive oil polyphenols enhance high-density lipoprotein function in humans: a randomized controlled trial. Arterioscler Thromb Vasc Biol 2014;34:2115-9.
28. Hernáez Á, Remaley AT, Farràs M, et al. Olive Oil Polyphenols Decrease LDL Concentrations and LDL Atherogenicity in Men in a Randomized Controlled Trial. J Nutr 2015;145:1692-7.
29. DeLany J P, Windhauser MM, Champagne CM, et al. Differential oxidation of individual dietary fatty acids in humans. Am J Clin Nutr 2000;72:905-11.
30. Marina AM, Man YB, Nazimah SA, et al. Antioxidant capacity and phenolic acids of virgin coconut oil. Int J Food Sci Nutr 2009;60(Suppl 2):114-23.
31. Kummerow FA. The negative effects of hydrogenated trans fats and what to do about them. Atherosclerosis 2009;205:458-65.
32. Goodman DS, Hulley SB, Clark LT. Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. The Expert Panel. Arch Intern Med 1988;148:36-69.
33. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-9.
34. Casas R, Sacanella E, Urpí-Sardà M, et al. The effects of the mediterranean diet on biomarkers of vascular wall infammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial. PLoS One 2014;9:e100084.
35. Casas R, Sacanella E, Urpí-Sardà M, et al. Long-term immunomodulatory effects of a mediterranean diet in adults at high risk of cardiovascular disease in the PREvención con DIeta MEDiterránea (PREDIMED) randomized controlled trial. J Nutr 2016;146:1684-93.
36. Li Y, Hruby A, Bernstein AM, et al. Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: a prospective cohort study. J Am Coll Cardiol 2015;66:1538-48.
37. Khaw KT, Friesen MD, Riboli E, et al. Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med 2012;9:e1001255.
38. Praagman J, Beulens JW, Alssema M, et al. The association between dietary saturated fatty acids and ischemic heart disease depends on the type and source of fatty acid in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort. Am J Clin Nutr 2016;103:356-65.
39. Forouhi NG, Koulman A, Sharp SJ, et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol 2014;2:810-8.
40. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010;7:e1000252.
41. Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013;346:e8707.
42. Smit LA, Mozaffarian D, Willett W. Review of fat and fatty acid requirements and criteria for developing dietary guidelines. Ann Nutr Metab 2009;55:44-55.